Review: could Novolog cause Cancer - Hodgkin's Lymphoma?


Summary

Cancer - hodgkin's lymphoma is reported only by a few people who take Novolog. We study 18,711 people who have side effects while taking Novolog from FDA and social media. Among them, 3 have Cancer - hodgkin's lymphoma. Find out below who they are, when they have Cancer - hodgkin's lymphoma and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Novolog

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. (latest outcomes from Novolog 21,697 users)

Cancer - Hodgkin's Lymphoma

Cancer - hodgkin's lymphoma (cancer originating from white blood cells) has been reported by people with hypokalemia, abdominal pain upper, haematocrit decreased, cardiac arrest, pain in extremity (latest reports from 6,024 Cancer - hodgkin's lymphoma patients).

On Sep, 10, 2016

18,711 people reported to have side effects when taking Novolog.
Among them, 3 people (0.02%) have Cancer - Hodgkin's Lymphoma


Number of reports submitted per year:

Could Novolog cause Cancer - hodgkin's lymphoma?

Gender of people who have Cancer - Hodgkin's Lymphoma when taking Novolog *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Cancer - Hodgkin's Lymphoma when taking Novolog *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Multiple Sclerosis (1 person, 33.33%)
  • Hiv Test Positive (1 person, 33.33%)
  • Diabetic Neuropathy (1 person, 33.33%)

Top co-used drugs for these people *:

  • Lantus (3 people, 100.00%)
  • Revlimid (1 person, 33.33%)
  • Lisinopril (1 person, 33.33%)
  • Furosemide (1 person, 33.33%)
  • Aspirin (1 person, 33.33%)

Top other side effects for these people *:

  • Rash (1 person, 33.33%)
  • Neoplasm Progression (1 person, 33.33%)
  • Multiple Sclerosis Relapse (1 person, 33.33%)
  • Hyperglycaemia (1 person, 33.33%)
  • Drug Ineffective (1 person, 33.33%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Cancer - hodgkin's lymphoma when taking Novolog?

Browse all side effects of Novolog

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Cancer - hodgkin's lymphoma

Cancer - hodgkin's lymphoma

Could your condition cause Cancer - hodgkin's lymphoma

Cancer - hodgkin's lymphoma

Related studies

Can you answer these questions?

More questions for: Novolog, Cancer - hodgkin's lymphoma

You may be interested in these reviews

More reviews for: Novolog, Cancer - hodgkin's lymphoma


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.